PhaseRx
Seattle
About PhaseRx
PhaseRx is a startup company based in Seattle focused on the delivery of siRNA and other macromolecular therapeutics. The Company has attracted top-tier venture investors and was founded by its President, Robert Overell, Patrick Stayton and Allan Hoffman of the University of Washington, Oliver Press of Fred Hutchinson Cancer Research Center, and Paul Johnson, the Company's Chief Scientific Officer. PhaseRx was conceived on the basis of using novel polymer technology to deliver siRNA. The Company believes the technology also has significant applications for the delivery of other macromolecular therapeutics.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $31.0M
- Funding stage: IPO
- Last round: Debt Financing (Dec 2015)
- Ticker: nasdaq:PZRX
- Website: phaserx.com
- Phone: (206)805-6300
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/phaserx-2112741 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.